Searchable abstracts of presentations at key conferences in endocrinology

ea0063p1066 | Pituitary and Neuroendocrinology 3 | ECE2019

Reduction in serum biomarkers of acromegaly post-surgery and post-pharmacotherapy: are insulin-like growth factor (IGF)-1 and soluble (s)Klotho levels decreased to a similar extent?

Anand Gurpreet , Bernays Rene , Neidert Marian , Regli Luca , Sze Lisa , Tschopp Oliver , Zwimpfer Cornelia , Schmid Christoph

Background, aims: Acromegaly is caused by excessive growth hormone (GH) secretion, usually by a pituitary adenoma. Surgical removal of the GH-producing adenoma is the most effective treatment. Drug treatment is second-line option. Earlier work suggested Soluble (s)Klotho levels to be a supplementary biomarker to IGF-1. We tested whether IGF-1 and sKlotho serum levels show a concomitant reduction under medical treatment. If yes, is the extent of reduction in serum IGF-1 and sKl...

ea0038p23 | Clinical biochemistry | SFEBES2015

Using SDHB immunostaining in characterising pheochromocytoma and paraganglioma

Velusamy Anand , Izatt Louise , Mufaddal Moonim , McGowan Barbara , Hubbard Jonathan , Obholzer Rupert , Carroll Paul

Germline mutations account for hereditary phaeochromocytoma (PCC) and paraganglioma (PGL) syndromes. SDHB immunostaining can be used to functionally characterise SDH status on PCC and PGL tumours. Genetic testing of multiple candidate genes is increasingly performed in patients presenting with PCC/PGL tumours. We investigated the effectiveness of SDHB immunostaining as an initial screening tool in identifying SDH mutations.This was a retrospecti...

ea0025oc3.1 | Pituitary and thyroid | SFEBES2011

Development of a novel mass spectroscopy-based method for determining serum IGF1: assessment in a cohort of newly diagnosed subjects with acromegaly

Halsall David , Kay Richard , Taylor Kevin , Annamalai Anand , Kandasamy Narayanan , Wark Gwen , Pleasance Steve , Gurnell Mark

Background: The recently published ‘Consensus on Criteria for Cure of Acromegaly’ (Giustina et al. JCEM, 2010) highlighted concerns regarding the quality of currently available insulin-like growth factor 1 (IGF1) immunoassays which may contribute, at least in part, to the discordance between GH and IGF1 that is observed in up to 30% of patients with acromegaly after treatment. The development of mass spectroscopy (MS)-based technology has been proposed ...

ea0024p7 | (1) | BSPED2010

Glucocorticoid hypofunction in Myotonic Dystrophy

Anand G , McHale E , Ray N , McShane M A , Ryan F J

Myotonic Dystrophy is an autosomal dominant multi-system disorder characterised by muscle weakness and myotonia, with associated cardiac, ophthalmic, gastrointestinal and endocrine abnormalitiesA 16-year-old boy was referred with a 2 months history of difficulty releasing his hand-grip and problems with swallowing. The clinical diagnosis of myotonic dystrophy 1 was confirmed with genetic testing with the detection of a DMPK expansion mutation. During inv...

ea0024p50 | (1) | BSPED2010

Why the confusion in Hashimoto’s encephalopathy?

Anand G , Jayasekara A , Ibitoye R , Ray N , McShane M A , Ryan F J

Neurological complications of thyroid disease are well recognised; however the distinct clinical entity of encephalopathy associated with autoimmune thyroid disease has been only occasionally reported in the paediatric population. We describe a case of Hashimoto’s encephalopathy (HE) in a teenage girl.A 13-year-old girl presented with seizures and prolonged confusion. Baseline blood tests, CSF analysis and CT Brain were essentially normal. She was d...

ea0011p3 | Bone | ECE2006

The effect of local radiotherapy on osteoprotegrin levels in patients with bone metastases

Abdulkhaliq A , Foo C , Baffoe G , Anand P , Girgis SI , Quigley C

Pain due to bone metastases can be relieved by local radiotherapy (RT). The mechanism of pain relief by RT has not been fully elucidated. Inhibition of bone resorption has been proposed as a possible mechanism. Osteoprotegrin (OPG) has been shown to block behaviours indicative of pain in mice with bone metastases and to diminish bone destruction (Honore et al., 2000, Nature Medicine 6; 521–8).The aim of this study was to evaluate serum OPG le...

ea0056p139 | Endocrine tumours and neoplasia | ECE2018

Prevalence of undiagnosed Medullary Thyroid Carcinoma and Phaeochromocytoma in MEN2A syndrome revealed by cascade screening

Kumar Rakshit , Joshi Mamta , Velusamy Anand , Mcgowan Barbara , Powrie Jake , Izatt Louise , Carroll Paul

Mutations in the RET gene are responsible for Multiple Endocrine Neoplasia type 2A (MEN2A), characterised by Medullary Thyroid Carcinoma (MTC) and Pheochromocytoma (PCC). It is well recognised that there is a genotype-phenotype correlation regarding likelihood of endocrine tumour development. The American Thyroid Association (ATA) has published predictive grading to guide clinical management of patients with RET mutations.Aim: In this study, we aim to as...

ea0073aep388 | Endocrine-Related Cancer | ECE2021

Clinical, genetic & imaging characteristics of mediastinal paraganglioma – a case series

Quinn Mark , Paul Carroll , McGowan Barbara , Joshi Mamta , Izatt Louise , Velusamy Anand

IntroductionParagangliomas (PGLs) are neuroendocrine tumours that arise from neural crest-derived chromaffin cells. They can develop anywhere these cells exist from the base of the skull to the pelvis. All PGLs have neuro-secretory potential and can produce symptoms due to catecholamine excess. While the majority are benign they do have malignant potential. Mediastinal PGLs are rare and often have a strong genetic predisposition. A higher proportion of t...

ea0094p338 | Endocrine Cancer and Late Effects | SFEBES2023

Papillary thyroid cancer occuring in thyroglossal duct cyst- a rare presentation

Sathyanarayan Sheela , Madan Arina , Salema Valmiki , Velusamy Anand , Anandappa Samanth , Ul-Hassan Fahim , Hubbard Jonathan

Thyroglossal duct cysts are the most frequently occurring congenital cervical anomaly, however the development of Papillary Thyroid Cancer (PTC) in these are very rare, with an incidence around 1%. We present two cases of PTC identified in thyroglossal duct cysts from our services. A 26-year-old lady with a 1-year history of midline neck swelling, was investigated with a neck ultrasound which showed a 2.8cm septated thyroglossal duct cyst and U2 thyroid cyst. She underwent a F...

ea0095p93 | Bone 2 | BSPED2023

Hematopoietic stem cell transplantation partially rescued the bone phenotype and prevented upper airway obstruction in a boy with pycnodysostosis: A case report

Lordudass Alexis Anand Dass , Wynn Rob , Wilkinson Stuart , Padilela Raja , Chinoy Amish , Mughal M. Zulf

Introduction: Pycnodysostosis (PYCD) is a rare autosomal recessive disorder caused by a mutation in cathepsin K (CTSK) gene resulting in increased bone density. The condition is characterised by short stature, acro-osteolysis of distal phalanges, osteosclerosis with increased bone fragility, dysplastic clavicula, delayed closure of sutures, mandibular hypoplasia, dental crowding and upper airway obstruction, causing obstructive sleep apnoea syndrome (OSAS). We...